Table 4.
Results of regression analyses (patients only).
| Variable | Standardized beta | T | p | R2 | F[df] | R2 change | Sign. Fchange | |
|---|---|---|---|---|---|---|---|---|
| Model 1 | 0.471 | F[6, 79] = 11.725*** | 0.471 | 11.725*** | ||||
| Step 1 | Age | 0.729 | 7.756 | 0.000 | ||||
| Sex | −0.157 | −1.775 | 0.080 | |||||
| Education | −0.193 | −2.017 | 0.047 | |||||
| Chlorpromazine (CPZ) equivalents | 0.086 | 0.954 | 0.343 | |||||
| Institutionalization | −0.266 | −2.807 | 0.006 | |||||
| Age at disease onset | −0.270 | −2.881 | 0.005 | |||||
| Model 2 | 0.530 | F[7, 75] = 12.060*** | 0.059 | 9.377** | ||||
| Step 1 | Age | 0.671 | 7.295 | 0.000 | ||||
| Sex | −0.184 | −2.132 | 0.036 | |||||
| Education | −0.051 | −0.488 | 0.627 | |||||
| CPZ equivalents | −0.034 | −0.357 | 0.722 | |||||
| Institutionalization | −0.304 | −3.316 | 0.001 | |||||
| Age at disease onset | −0.240 | −2.667 | 0.009 | |||||
| Step 2 | AES sum score | 0.305 | 3.062 | 0.003 | ||||
| Model 3 | 0.578 | F[9, 73] = 11.112*** | 0.049 | 4.196* | ||||
| Step 1 | Age | 0.670 | 7.452 | 0.000 | ||||
| Sex | −0.202 | −2.425 | 0.018 | |||||
| Education | −0.017 | −0.168 | 0.867 | |||||
| CPZ equivalents | −0.108 | −1.136 | 0.260 | |||||
| Institutionalization | −0.201 | −2.113 | 0.038 | |||||
| Age at disease onset | −0.160 | −1.748 | 0.085 | |||||
| Step 2 | AES sum score | 0.352 | 3.573 | 0.001 | ||||
| Step 3 | SAPS sum score | 0.182 | 1.356 | 0.179 | ||||
| Brief Psychiatric Rating Scale thought disturbance | 0.093 | 0.674 | 0.502 | |||||
*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001.